From: Identifying and managing refractory migraine: barriers and opportunities?
 | Oral/Nasal | Injectable | Neurostimulation |
---|---|---|---|
Acute | • Oral and Intranasal Triptans • High dose NSAIDS • Paracetamol • Antiemetics | • Subcutaneous sumatriptan | • Transcranial magnetic stimulation • External trigeminal nerve stimulation (Cefaly) • Vagal nerve stimulation |
Preventive | • Beta-blockers: Propranolol, Metoprolol, Timolol, Atenolol, Nadolol • Anticonvulsants: Topiramate, Valproate • Tricyclics: Amitriptyline • SNRI: Venlafaxine • Angiotensin pathway blockers: Lisinopril, Candesartan • Calcium channel blockers: Flunarizine • Nutraceuticals: Riboflavin, Coenzyme Q10, Magnesium, Feverfew | • Onabotulinumtoxin A • CGRP-pathway monoclonal antibodies | • External trigeminal nerve stimulation (Cefaly) • Transcranial magnetic stimulation • Occipital nerve stimulation • High cervical spinal cord stimulation |
Transitional | • Corticosteroids | • Greater occipital nerve block • Multiple cranial nerve blocks • Intravenous dihydroergotamine • Intravenous lidocaine |  |